Immune Modulation of Hypertension
Immune Modulation of Hypertension
批准号:
9223751
负责人:
Kathryn L Sandberg
金额:
$48.06万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-15 至 2019-02-28
关键词:
Adoptive TransferAgeAge of OnsetAngiotensin IIAngiotensinsAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAttenuatedB-LymphocytesBlood PressureCD3 AntigensCD8-Positive T-LymphocytesCD8B1 geneCardiovascular DiseasesCell physiologyDevelopmentEquilibriumEstradiolEstrogensFemaleGeneticGonadal structureHormonalHypertensionImmuneImmune systemImmunityInflammatoryInfusion proceduresInjury to KidneyInterleukin-10Interleukin-17Kidney DiseasesLeadLeukocytesLinkMediatingMesenteryModelingMusOrganOvarian hormonePhenotypePlayPredispositionPremenopauseRag1 MouseRegulationResearchResistanceRoleSex CharacteristicsSex ChromosomesT cell responseT-LymphocyteT-Lymphocyte SubsetsTNF geneTesticular HormonesTestingTestosteroneWomanarteriolecardiovascular risk factorcytokineimmunoregulationmalemennovel therapeutic interventionpressurepreventpublic health relevancereceptorresponsesex
中文摘要
描述(由申请人提供):最近的研究表明,T细胞可以调节动脉压。我们发现,过继转移男性而不是女性的CD 3+,CD 4+和CD 8 + T细胞可以介导雄性Rag 1缺陷小鼠的Ang II依赖性高血压。这些观察结果表明,T细胞的性别特异性决定了免疫系统调节高血压的抵抗力和脆弱性。在目标1中,我们将确定T细胞介导的对由Ang II输注诱导的雄性Rag 1-/-宿主中的高血压的易感性和抵抗性是否是由于性染色体(XX vs XY)对T细胞供体的性腺依赖性或性腺非依赖性作用,以及这些作用如何与终末器官损伤和T细胞反应联系起来。在目标2中,我们将确定在雄性Rag 1-/-宿主中对Ang II输注的性别特异性T细胞亚群应答是否是由于T细胞血管紧张素1型和2型受体(AT 1 R和AT 2 R)的性别差异以及这些受体介导的T细胞效应如何与血压、终末器官损伤和T细胞功能联系。目的3将确定促炎和抗炎细胞因子在CD 4+和CD 8+介导的对Ang II诱导的高血压的易感性和抵抗性中的作用,并将这些发现与终末器官损伤联系起来。在血管紧张素II依赖性高血压模型中,确定T细胞亚特异性和T细胞功能受性别调节的机制可能为绝经前女性与年龄匹配的男性相比高血压延迟发作提供解释。此外,发现与血管紧张素II诱导的高血压抵抗和易感性相关的免疫调节表型可以揭示T细胞亚群特异性靶点和治疗两性高血压的策略。
英文摘要
DESCRIPTION (provided by applicant): Recent studies indicate that T cells can modulate arterial pressure. We found that adoptive transfer of male but not female CD3+, CD4+ and CD8+ T cells can mediate Ang II-dependent hypertension in male Rag1 deficient mice. These observations indicate sex specific ations of T cells determine resistance and vulnerability in the regulation of hypertension by the immune system. In aim 1, we will determine if T cell-mediated susceptibility and resistance to hypertension induced by Ang II infusion in the male Rag1-/- host is due to gonad-dependent or gonad-independent effects of the sex chromosomes (XX vs XY) on the T cell donor and how these effects link to end organ damage and T cell responses. In aim 2, we will determine if sex-specific T cell subset responses to Ang II infusion in the male Rag1-/- host are due to sex differences in T cell angiotensin type 1 and type 2 receptors (AT1R and AT2R) and how these receptor- mediated T cell effects link to blood pressure, end organ damage and T cell function. Aim 3 will determine the role of pro- and anti-inflammatory cytokines in CD4+ and CD8+- mediated susceptibility and resistance to Ang II-induced hypertension and link these findings to end organ damage. Defining the mechanisms by which T cell sub- specification and T cell function are regulated by sex in a model of Ang II-dependent hypertension may provide an explanation for the delayed onset of hypertension in premenopausal women compared with age-matched men. Furthermore, discovering immune regulatory phenotypes associated with resistance and susceptibility to hypertension induced by Ang II could uncover T cell subset specific targets and strategies for treating hypertension in both sexes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting angiotensin II in cognitive impairment associated with ovarian hormone loss
-
批准号:9751159
-
项目类别:
-
资助金额:$19.13万
-
财政年份:2018
-
负责人:Kathryn L Sandberg
-
依托单位:
Immune Modulation of Hypertension
-
批准号:8816737
-
项目类别:
-
资助金额:$50.54万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS)
-
批准号:9084750
-
项目类别:
-
资助金额:$54.21万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
Aging impairments in angiotensin type 1 receptor actions
-
批准号:8969870
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
Translational Biomedical Science Training Grant
-
批准号:10086570
-
项目类别:
-
资助金额:$44.79万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
Aging impairments in angiotensin type 1 receptor actions
-
批准号:9120727
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
Translational Biomedical Science Training Grant
-
批准号:10399488
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2015
-
负责人:Kathryn L Sandberg
-
依托单位:
2012 Angiotensin Gordon Research Conference and Gordon Research Seminar
-
批准号:8319065
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2012
-
负责人:Kathryn L Sandberg
-
依托单位:
Gonadotropins in a female model of age-induced hypertension
-
批准号:8322633
-
项目类别:
-
资助金额:$15.73万
-
财政年份:2011
-
负责人:Kathryn L Sandberg
-
依托单位:
Gonadotropins in a female model of age-induced hypertension
-
批准号:8104853
-
项目类别:
-
资助金额:$23.03万
-
财政年份:2011
-
负责人:Kathryn L Sandberg
-
依托单位:
MOLECULAR BIOLOGY AND BIOCHEMISTRY CORE
-
批准号:8148036
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2010
-
负责人:Kathryn L Sandberg
-
依托单位:
POSTTRANSCRIPTIONAL REGULATION OF ANGIOTENSIN RECEPTORS
-
批准号:7822195
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2009
-
负责人:Kathryn L Sandberg
-
依托单位:
HORMONAL REGULATION OF ANGIOTENSIN RECEPTORS
-
批准号:7886268
-
项目类别:
-
资助金额:$1.29万
-
财政年份:2009
-
负责人:Kathryn L Sandberg
-
依托单位:
HORMONAL REGULATION OF ANGIOTENSIN RECEPTORS
-
批准号:7886267
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2009
-
负责人:Kathryn L Sandberg
-
依托单位:
Molecular Biology and Biochemistry Core
-
批准号:7218289
-
项目类别:
-
资助金额:$19.81万
-
财政年份:2006
-
负责人:Kathryn L Sandberg
-
依托单位:
Association between the Y chromosome and androgens
-
批准号:6879305
-
项目类别:
-
资助金额:$3.98万
-
财政年份:2005
-
负责人:Kathryn L Sandberg
-
依托单位:
Association between the Y chromosome and androgens
-
批准号:7252546
-
项目类别:
-
资助金额:$3.16万
-
财政年份:2005
-
负责人:Kathryn L Sandberg
-
依托单位:
Association between the Y chromosome and androgens
-
批准号:7007714
-
项目类别:
-
资助金额:$3.25万
-
财政年份:2005
-
负责人:Kathryn L Sandberg
-
依托单位:
Sex and Gene Expression
-
批准号:6941051
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2005
-
负责人:Kathryn L Sandberg
-
依托单位:
Sex and Gene Expression Conference
-
批准号:6755418
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2004
-
负责人:Kathryn L Sandberg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: